Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database

Keyphrases

• Clinical Outcomes 100%
• Triple-negative Breast Cancer 100%
• Adjuvant Chemotherapy 100%
• Neoadjuvant 100%
• Neoadjuvant Chemotherapy 100%
• National Cancer Database 100%
• Pathological Complete Response 46%
• Non-pathogenic 26%
• Breast Cancer Patients 13%
• Primary Tumor 6%
• Relative Risk 6%
• Chemotherapy 6%
• Kaplan-Meier Estimator 6%
• Baseline Characteristics 6%
• Therapeutic Efficacy 6%
• Unadjusted Analyses 6%
• Charlson 6%
• Breast Cancer Outcomes 6%
• Log-rank Test 6%
• Localized Disease 6%
• Selection Bias 6%
• Trend Analysis 6%
• Comorbidity Index 6%
• Black Race 6%
• 5-year OS 6%
• Log-binomial Model 6%
• Response Status 6%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Neoadjuvant Chemotherapy 100%
• Adjuvant Chemotherapy 100%
• Triple Negative Breast Cancer 100%
• Biological Marker 6%
• Primary Tumor 6%
• Clinical Stage 6%
• Retrospective Study 6%
• Student T Test 6%
• Survival Analysis 6%
• Log Rank Test 6%
• Selection Bias 6%
• Comorbidity 6%
• Diseases 6%
• Chemotherapy 6%